There is heterogeneity of bronchiectasis within α1-AT deficiency; hence, there is a need for broader screening strategies to ensure timely access to emerging therapies and inclusion in ongoing research efforts https://bit.ly/4nCZsxM.
Kang et al. (Thu,) studied this question.